Acetosulfone

Acetosulfone

SCHEMBL10697113

CC(=O)NS(=O)(=O)c1cc(N)ccc1S(=O)(=O)c1ccc(N)cc1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.64
DHFR P00374 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
PKM P14618 3/20 0.51
CYP2C19 P33261 1/20 0.51
NPC1 O15118 1/20 0.49
ALDH1A1 P00352 3/20 0.44
LMNA P02545 2/20 0.43
HTR6 P50406 2/20 0.43
MPO P05164 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
HSD11B1 P28845 1/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14544359 0.88 DHFR (0.56) TSHRDHFRSMN1; SMN2TDP1PKM
SCHEMBL11946661 0.86 TSHR (0.54) TSHRDHFRSMN1; SMN2TDP1PKM
Sulfacetamide SCHEMBL28122264 0.79 SMN1; SMN2 (1.00) TSHRDHFRSMN1; SMN2TDP1PKM
Sulfacetamide SCHEMBL40863 0.79 SMN1; SMN2 (1.00) TSHRDHFRSMN1; SMN2TDP1PKM
Sulfacetamide SCHEMBL29207414 0.77 SMN1; SMN2 (0.96) TSHRDHFRSMN1; SMN2TDP1PKM
Sulfacetamide SCHEMBL16097762 0.77 SMN1; SMN2 (0.96) TSHRDHFRSMN1; SMN2TDP1PKM
Sulfacetamide SCHEMBL23317 0.77 SMN1; SMN2 (0.96) TSHRDHFRSMN1; SMN2TDP1PKM
Sulfacetamide SCHEMBL2503539 0.77 SMN1; SMN2 (0.96) TSHRDHFRSMN1; SMN2TDP1PKM
Sulfacetamide SCHEMBL3912378 0.77 SMN1; SMN2 (0.96) TSHRDHFRSMN1; SMN2TDP1PKM
Sulfacetamide SCHEMBL28182511 0.77 SMN1; SMN2 (0.96) TSHRDHFRSMN1; SMN2TDP1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0255100-A2 Use of trimetrexate and its salts for the preparation of pharmaceutical compositions for treating infections of the mycobacterium-avium-intracellulare complex WARNER-LAMBERT COMPANY (US) 1988-02-03 EP claimed
EP-4382109-A1 USE OF A COMPOSITE MATERIAL Heraeus Medical GmbH (DE) 2024-06-12 EP disclosed